ST-503

N/A

Report date: 2026/05/02 20:00:18

Base Information

Drug NameST-503
Drug Alias NameST-503
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionSodium channel protein type IX alpha subunit inhibitors
TargetsSodium channel protein type IX alpha subunit
Therapy Area/IndicationsSmall Fiber NeuropathyNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSangamo Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSangamo Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSmall Fiber NeuropathyNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A